Anti-FOXA1抗体- ChIP Grade (ab23738)

发表研究结果有使用 ab23738?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab23738 被引用在 35 文献中.

  • Yang YA  et al. FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function. Nucleic Acids Res 44:8153-64 (2016). Human . PubMed: 27257062
  • Horimoto Y  et al. Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases. Br J Cancer 112:345-51 (2015). WB, IHC-P ; Human . PubMed: 25422910
  • Griffon A  et al. Integrative analysis of public ChIP-seq experiments reveals a complex multi-cell regulatory landscape. Nucleic Acids Res 43:e27 (2015). PubMed: 25477382
  • Franco HL  et al. TNFa signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome. Mol Cell 58:21-34 (2015). Human . PubMed: 25752574
  • Viart V  et al. Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis. Eur Respir J 45:116-28 (2015). PubMed: 25186262
  • Thrane S  et al. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells. Oncogene N/A:N/A (2014). PubMed: 25362855
  • Nguyen DH  et al. Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice. Cancer Res 74:7149-58 (2014). PubMed: 25281718
  • Gromov P  et al. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. PLoS One 9:e112024 (2014). IHC ; Human . PubMed: 25389781
  • Qiu M  et al. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer. BMC Cancer 14:78 (2014). WB, IHC-P, ChIP ; Mouse, Human . PubMed: 24512546
  • Tangen IL  et al. Switch in FOXA1 status associates with endometrial cancer progression. PLoS One 9:e98069 (2014). IHC-P ; Human . PubMed: 24849812
  • Jin HJ  et al. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Nat Commun 5:3972 (2014). PubMed: 24875621
  • Sutinen P  et al. SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner. Nucleic Acids Res N/A:N/A (2014). ChIP . PubMed: 24981513
  • Quintin J  et al. Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities. Mol Cell Biol 34:2418-36 (2014). PubMed: 24752895
  • Demars J  et al. Genetic variants within the second intron of the KCNQ1 gene affect CTCF binding and confer a risk of Beckwith-Wiedemann syndrome upon maternal transmission. J Med Genet 51:502-11 (2014). PubMed: 24996904
  • Fogarty MP  et al. Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genet 10:e1004633 (2014). ChIP ; Human . PubMed: 25211022
  • Caravaca JM  et al. Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev 27:251-60 (2013). WB, ChIP ; Human . PubMed: 23355396
  • Sahu B  et al. FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells. Cancer Res : (2013). PubMed: 23269278
  • Jin HJ  et al. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis. Cancer Res 73:3725-36 (2013). Mouse . PubMed: 23539448
  • Gaughan L  et al. KDM4B is a master regulator of the estrogen receptor signalling cascade. Nucleic Acids Res 41:6892-904 (2013). PubMed: 23723241
  • Meyer KB  et al. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 93:1046-60 (2013). PubMed: 24290378
  • Watanabe H  et al. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes Dev 27:197-210 (2013). WB, ChIP ; Human . PubMed: 23322301
  • Chen S  et al. Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation. J Biol Chem 287:8571-83 (2012). WB . PubMed: 22275373
  • Naderi A  et al. Cross-regulation between FOXA1 and ErbB2 Signaling in Estrogen Receptor-Negative Breast Cancer. Neoplasia 14:283-96 (2012). WB, ChIP, IHC-FoFr ; Human . PubMed: 22577344
  • Stine ZE  et al. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. Hum Mol Genet 20:3746-56 (2011). WB . PubMed: 21737465
  • Chatterjee S  et al. Conserved and non-conserved enhancers direct tissue specific transcription in ancient germ layer specific developmental control genes. BMC Dev Biol 11:63 (2011). WB, EMSA ; Zebrafish . PubMed: 22011226
  • Hurtado A  et al. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43:27-33 (2011). ChIP ; Human . PubMed: 21151129
  • Sahu B  et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J 30:3962-76 (2011). PubMed: 21915096
  • Yu J  et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17:443-54 (2010). ChIP ; Human . PubMed: 20478527
  • Kunisada M  et al. Requirement for Shh and Fox family genes at different stages in sweat gland development. Hum Mol Genet 18:1769-78 (2009). IHC-P ; Mouse . PubMed: 19270025
  • Nucera C  et al. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res 15:3680-9 (2009). WB ; Human . PubMed: 19470727
  • Wang Q  et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138:245-56 (2009). WB, ChIP ; Human . PubMed: 19632176
  • Jia L  et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 5:e1000597 (2009). EMSA ; Human . PubMed: 19680443
  • Silva JP  et al. Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 462:646-50 (2009). WB, IHC-FoFr ; Mouse . PubMed: 19956259
  • Belikov S  et al. FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter. Mol Cell Biol 29:5413-25 (2009). PubMed: 19687299
  • Lupien M  et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132:958-70 (2008). WB, ChIP, ChIP/Chip ; Human . PubMed: 18358809